制造病毒载体疫苗的战略和技术考虑 生物医学先进研究和开发权威威胁

Lindsay A Parish1, Shyam Rele2, Kimberly A Hofmeyer1

  • 1CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington, DC 20201, USA.

Vaccines
|January 24, 2025
PubMed
概括

病毒载体疫苗对于对抗新兴传染病和为流行病做好准备至关重要. 提高这些先进疫苗技术的制造能力是未来公共卫生安全的关键.